{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:58:18Z","timestamp":1776693498101,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gofs.2021.03.028","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T20:52:25Z","timestamp":1616273545000},"page":"474-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["La gestion des effets secondaires sous traitement hormonal de la m\u00e9nopause\u00a0: saignements ut\u00e9rins anormaux. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi"],"prefix":"10.1016","volume":"49","author":[{"given":"N.","family":"Hamdaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Boubli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"5\u00a0Pt 1","key":"10.1016\/j.gofs.2021.03.028_bib0210","first-page":"693","article-title":"Cyclic hormone replacement therapy using quarterly progestin","volume":"83","author":"Ettinger","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2021.03.028_bib0215","series-title":"Commission de la transparence DUOVA","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)","year":"2014"},{"key":"10.1016\/j.gofs.2021.03.028_bib0220","series-title":"Commission de la transparence KLIOGEST","author":"Haute Autorit\u00e9 de Sant\u00e9 (HAS)","year":"2016"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13697137.2014.999661","article-title":"Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52\u00a0weeks of therapy","volume":"18","author":"Mattsson","year":"2015","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13697130310001651481","article-title":"A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen","volume":"7","author":"Mattsson","year":"2004","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(01)00245-6","article-title":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study","volume":"40","author":"Bruhat","year":"2001","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.maturitas.2005.07.003","article-title":"A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness","volume":"53","author":"Christodoulakos","year":"2006","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/cmt.5.1.60.69","article-title":"A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptomcontrol, bleeding pattern, lipid profile and tolerability","volume":"5","author":"Baracat","year":"2002","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0250","first-page":"183","article-title":"Comparing the effects of continuous hormonereplacement therapy and tibolone on the genital tract of menopausal women; arandomized controlled trial","volume":"11","author":"Saeideh","year":"2010","journal-title":"J Reprod Infertil"},{"issue":"8928","key":"10.1016\/j.gofs.2021.03.028_bib0255","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(94)91640-3","article-title":"Is the timing of withdrawal bleeding a guide to endometrial safetyduring sequential oestrogen-progestagen replacement therapy? UK Continuous, Combined HRT Study Investigators","volume":"344","author":"Sturdee","year":"1994","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.028_bib0260","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.fertnstert.2003.10.043","article-title":"Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study","volume":"81","author":"Omodei","year":"2004","journal-title":"Ferti Steril"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1469-0705.2000.00091.x","article-title":"Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound\/hysteroscopic study","volume":"15","author":"Omodei","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00042192-199906030-00005","article-title":"A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy","volume":"6","author":"Archer","year":"1999","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.028_bib0275","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0002-9378(95)90483-2","article-title":"Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: a Nordic multicenter study","volume":"172","author":"Karlsson","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.gofs.2021.03.028_bib0280","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.280.17.1510","article-title":"Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities","volume":"280","author":"Smith-Bindman","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0285","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/PGP.0000000000000344","article-title":"Endometrial thickness as measured by transvaginal ultrasound and the corresponding histopathologic diagnosis in women with postmenopausal bleeding","volume":"36","author":"Patel","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"10.1016\/j.gofs.2021.03.028_bib0290","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/aogs.13022","article-title":"Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy","volume":"95","author":"Visser","year":"2016","journal-title":"Acta Obste tGynecol Scand"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00404-010-1604-0","article-title":"Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography and hysteroscopy in postmenopausal bleeding","volume":"284","author":"Bingol","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.028_bib0300","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/gme.0b013e3180333a6b","article-title":"Comparison of transvaginal ultrasonography and saline infusion sonohysterography in evaluating the endometrial cavity in pre- and postmenopausal women with abnormal uterine bleeding","volume":"14","author":"Erdem","year":"2007","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmig.2007.10.014","article-title":"Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy","volume":"15","author":"Angioni","year":"2008","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0310","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00042192-199906030-00005","article-title":"A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy","volume":"6","author":"Archer","year":"1999","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.gofs.2021.03.028_bib0315","first-page":"292","article-title":"Comparison of diagnostic methods for evaluation of postmenopausal bleeding","volume":"35","author":"Nergiz","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2021.03.028_bib0320","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/1055-9965.1459.13.9","article-title":"Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure","volume":"13","author":"Sit","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0325","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1469-0705.2002.00800.x","article-title":"An algorithm including results of gray-scale and power Doppler ultrasound examination to predict endometrial malignancy in women with postmenopausal bleeding","volume":"20","author":"Epstein","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2021.03.028_bib0330","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0015-0282(16)58329-0","article-title":"Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: acomparison with postmenopausal bleeding","volume":"65","author":"Nagele","year":"1996","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-5122(02)00272-4","article-title":"Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users","volume":"43","author":"Perrone","year":"2002","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.028_bib0340","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"275","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1074-3804(96)80102-2","article-title":"Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy","volume":"4","author":"Maja","year":"1996","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.gofs.2021.03.028_bib0350","first-page":"1053","article-title":"Transdermal hormone replacement therapy in post-menopausal women with uterine leiomyomas","volume":"98","author":"Palomba","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2021.03.028_bib0355","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5122(00)00115-8","article-title":"Effects of hormone replacement therapy on postmenopausal uterine myoma","volume":"35","author":"Colacurci","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.gofs.2021.03.028_bib0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0301-2115(99)00115-3","article-title":"A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in post-menopausal women with uterine myomas","volume":"88","author":"Fedele","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2021.03.028_bib0365","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0029-7844(95)00172-N","article-title":"Uterine bleeding on hormone replacement: the importance of intra- uterine structural abnormalities","volume":"86","author":"Akkad","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2021.03.028_bib0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/mi.2011.011111","article-title":"Postmenopausal vaginal bleeding in women using hormone replacement therapy","volume":"18","author":"Burbos","year":"2012","journal-title":"Menopause Int"},{"issue":"8","key":"10.1016\/j.gofs.2021.03.028_bib0375","first-page":"CD000402","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02940316","article-title":"Effect of hormone replacement therapy on postmenopausal endometrial bleeding","volume":"13","author":"Magyar","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.gofs.2021.03.028_bib0385","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.299.6699.601-a","article-title":"Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants","volume":"299","author":"Gangar","year":"1989","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.gofs.2021.03.028_bib0390","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1297-9589(02)00336-3","article-title":"Observance du traitement hormonal substitutif de la m\u00e9nopause: effet d\u2019un programme d\u2019\u00e9ducation original. L\u2019\u00e9tude COMET","volume":"30","author":"Serfaty","year":"2002","journal-title":"Gynecol Obstet Fertil"},{"issue":"4","key":"10.1016\/j.gofs.2021.03.028_bib0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2125.2002.01683.x","article-title":"St John's wort (Hypericumperforatum): drug interactions and clinical outcomes","volume":"54","author":"Henderson","year":"2002","journal-title":"Br J Clinical Pharmacol"},{"issue":"315","key":"10.1016\/j.gofs.2021.03.028_bib0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bmj.315.7099.37","article-title":"Management of abnormal bleeding in women receiving hormone replacement therapy","volume":"7099","author":"Spencer","year":"1997","journal-title":"BMJ"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:40:51Z","timestamp":1762854051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718921000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2468718921000805"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.028","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La gestion des effets secondaires sous traitement hormonal de la m\u00e9nopause\u00a0: saignements ut\u00e9rins anormaux. RPC Les femmes m\u00e9nopaus\u00e9es du CNGOF et du GEMVi","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}